COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 2 for:    instiladrin
Previous Study | Return to List | Next Study

INSTILADRIN® in Patients With Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02773849
Recruitment Status : Active, not recruiting
First Posted : May 16, 2016
Last Update Posted : May 21, 2020
Society of Urologic Oncology Clinical Trials Consortium
Information provided by (Responsible Party):
FKD Therapies Oy

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : May 24, 2019
Estimated Study Completion Date : August 31, 2022
Certification/Extension First Submitted : May 11, 2020